nitroxoline has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, BY; He, YM; Jiang, SY; Liu, JB; Mao, XL; Zeng, YY; Zhang, ZB; Zhao, J; Zhou, XM | 1 |
| Ji, CH; Shi, MH; Yu, JG | 1 |
2 other study(ies) available for nitroxoline and Lung Neoplasms
| Article | Year |
|---|---|
TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; DNA-Binding Proteins; Humans; Lung Neoplasms; Nitroquinolines; Phosphoric Monoester Hydrolases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; TOR Serine-Threonine Kinases; Ubiquitination | 2022 |
Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small-cell lung cancer.
Topics: Apoptosis; Carcinoma, Small Cell; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Evaluation, Preclinical; Humans; Lung Neoplasms; Nitroquinolines; Proteasome Endopeptidase Complex; Proteolysis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-mdm2 | 2019 |